Market leadership Clinical Research Advantage operates the largest wholly owned network of clinical trial sites in the country, with a history dating back to 1992 and a track record of over 11,000 completed trials. This positions them as a reliable partner for sponsors seeking broad site access and rapid patient recruitment.

Full service scope CRA supports phase II to IV trials across pharmaceutical, biotech and medical device sectors, offering nationwide site coverage and in-clinic staff presence to accelerate recruitment and trial execution, which can appeal to sponsors looking to streamline operations with a single partner.

Growth opportunities Revenue is in the low nine-figure range with a mid-sized employee base, suggesting potential upsell avenues in expanded trial types, longer duration studies, and deeper CRO partnerships as sponsors scale their programs.

Competitive positioning With a historic integration of Radiant Research and Comprehensive Clinical Development, CRA demonstrates an ability to consolidate capabilities, offering a robust network that can compete with larger CROs on site access while maintaining flexible, sponsor-aligned delivery.

Fit for mid-market Compared to peers with larger employee counts and higher revenue, CRA sits in a mid-market niche ideal for sponsors seeking cost-effective, scalable trial operations with reliable recruitment and minimal vendor management overhead.